Skip to main content

Blog

Sarepta Announces FDA Approval to Begin ENDEAVOR Cohort 8 Dosing in Non-Ambulatory Individuals Living with Duchenne

...

Closing Out the Year with Connection & Community at PPMD Together

...

Avidity Biosciences Announces U.S. Managed Access Program for del-zota

...

Becker Muscular Dystrophy Series – Part 2: Cardiopulmonary Care

...

FDA Approves New Safety Warning and Revised Indication for ELEVIDYS

...

PPMD Continues to Drive Progress with Your Support

...

Tips for Smooth Holiday Travel

...

Welcoming the New Members of PAAC for Fall 2025

...

Advancing Brain and Behavior Care in Dystrophinopathy

...

Understanding Fat Embolism Syndrome (FES) and Protecting Bone Health

...